Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (3)

2021

  1. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)

    Drugs

  2. Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain

    Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882

  3. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    Drugs, Vol. 81, Núm. 15, pp. 1763-1774